Biological tests for major depressive disorder that involve leukocyte gene expression assays

Journal of Psychiatric Research

Volumn 66-67, Issue , 2015, Pages 1-6

  Watanabe, Shin Ya ^a   Iga, Jun Ichi ^a   Ishii, Kazuo ^b   Numata, Shusuke ^a   Shimodera, Shinji ^c   Fujita, Hirokazu ^c   Ohmori, Tetsuro ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^c KOCHI UNIVERSITY   (Japan)

Author keywords

Biomarker; Diagnostic test; Healthy subjects; Leukocyte gene expression; Major depressive disorder; PCR array

Indexed keywords

FLUVOXAMINE; MESSENGER RNA; MIRTAZAPINE; SERTRALINE; SULPIRIDE;

ADULT; ARHGAP24 GENE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC TEST; DISCRIMINANT ANALYSIS; DSM-IV; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION ASSAY; GENE IDENTIFICATION; HDAC5 GENE; HUMAN; IL1R2 GENE; LEUKOCYTE; LEUKOCYTE GENE EXPRESSION ASSAY; MAJOR DEPRESSION; MALE; PDGFC GENE; PDLIM5 GENE; PILOT STUDY; PRIORITY JOURNAL; PRNP GENE; REAL TIME POLYMERASE CHAIN REACTION; REPLICATION STUDY; SENSITIVITY AND SPECIFICITY; SLC6A4 GENE; BLOOD; DEPRESSIVE DISORDER, MAJOR; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROCEDURES; STATISTICAL MODEL;

ADULT; DEPRESSIVE DISORDER, MAJOR; DISCRIMINANT ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES; LINEAR MODELS; MALE; MIDDLE AGED; PILOT PROJECTS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 84930536424     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.03.004     Document Type: Article

References (32)

1. Andersen C.L., Jensen J.L., Orntoft T.F. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004, 64:5245-5250.
2. Arzt E. gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways. JClin Invest 2001, 108:1729-1733.
3. Belzeaux R., Formisano-Treziny C., Loundou A., Boyer L., Gabert J., Samuelian J.C., et al. Clinical variations modulate patterns of gene expression and define blood biomarkers in major depression. JPsychiatr Res 2010, 44:1205-1213.
4. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
5. Cepoiu M., McCusker J., Cole M.G., Sewitch M., Belzile E., Ciampi A. Recognition of depression by non-psychiatric physicians-a systematic literature review and meta-analysis. JGen Intern Med 2008, 23:25-36.
6. Connor T.J., Leonard B.E. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 1998, 62:583-606.
7. Faravelli C., Alessandra Scarpato M., Castellini G., Lo Sauro C. Gender differences in depression and anxiety: the role of age. Psychiatry Res 2013, 210:1301-1303.
8. Galecki P., Galecka E., Maes M., Orzechowska A., Berent D., Talarowska M., et al. Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development. Prog Neuropsychopharmacol Biol Psychiatry 2013, 45:117-124.
9. Hepgul N., Cattaneo A., Zunszain P.A., Pariante C.M. Depression pathogenesis and treatment: what can we learn from blood mRNA expression?. BMC Med 2013, 11:28.
10. Hobara T., Uchida S., Otsuki K., Matsubara T., Funato H., Matsuo K., et al. Altered gene expression of histone deacetylases in mood disorder patients. JPsychiatr Res 2010, 44:263-270.
11. Iga J., Ueno S., Yamauchi K., Motoki I., Tayoshi S., Ohta K., et al. Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine. Neurosci Lett 2005, 389:12-16.
12. Iga J., Ueno S., Yamauchi K., Numata S., Motoki I., Tayoshi S., et al. Gene expression and association analysis of LIM (PDLIM5) in major depression. Neurosci Lett 2006, 400:203-207.
13. Iga J., Ueno S., Yamauchi K., Numata S., Tayoshi-Shibuya S., Kinouchi S., et al. Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:658-663.
14. Iga J., Ueno S., Yamauchi K., Numata S., Kinouchi S., Tayoshi-Shibuya S., et al. Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:628-632.
15. Iga J., Ueno S., Ohmori T. Molecular assessment of depression from mRNAs in the peripheral leukocytes. Ann Med 2008, 40:336-342.
16. Ingram R.J., Isaacs J.D., Kaur G., Lowther D.E., Reynolds C.J., Boyton R.J., et al. Arole of cellular prion protein in programming T-cell cytokine responses in disease. FASEB J 2009, 23:1672-1684.
17. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
18. Lee C., Zhang F., Tang Z., Liu Y., Li X. PDGF-C: a new performer in the neurovascular interplay. Trends Mol Med 2013, 19:474-486.
19. Levinson D.F. The genetics of depression: a review. Biol Psychiatry 2006, 60:84-92.
20. Miller A.H. Depression and immunity: a role for T cells?. Brain Behav Immun 2010, 24:1-8.
21. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
22. Numata S., Iga J., Nakataki M., Tayoshi S., Taniguchi K., Sumitani S., et al. Gene expression and association analyses of the phosphodiesterase 4B (PDE4B) gene in major depressive disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:527-534.
23. Ohmori T., Morita K., Saito T., Ohta M., Ueno S., Rokutan K. Assessment of human stress and depression by DNA microarray analysis. JMed Invest 2005, 52(Suppl.):266-271.
24. Papakostas G.I., Shelton R.C., Kinrys G., Henry M.E., Bakow B.R., Lipkin S.H., et al. Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol Psychiatry 2013, 18:332-339.
25. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry 2003, 160:1554-1565.
26. Shibata T., Yamagata H., Uchida S., Otsuki K., Hobara T., Higuchi F., et al. The alteration of hypoxia inducible factor-1 (HIF-1) and its target genes in mood disorder patients. Prog Neuropsychopharmacol Biol Psychiatry 2013, 43:222-229.
27. Spijker S., Van Zanten J.S., De Jong S., Penninx B.W., van Dyck R., Zitman F.G., et al. Stimulated gene expression profiles as a blood marker of major depressive disorder. Biol Psychiatry 2010, 68:179-186.
28. Tsao C.W., Lin Y.S., Chen C.C., Bai C.H., Wu S.R. Cytokines and serotonin transporter in patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:899-905.
29. Tsutsui S., Hahn J.N., Johnson T.A., Ali Z., Jirik F.R. Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis. Am J Pathol 2008, 173:1029-1041.
30. Watanabe S., Iga J., Nishi A., Numata S., Kinoshita M., Kikuchi K., et al. Microarray analysis of global gene expression in leukocytes following lithium treatment. Hum Psychopharmacol 2014, 29:190-198.
31. Watson S., Gallagher P., Smith M.S., Ferrier I.N., Young A.H. The dex/CRH test-is it better than the DST?. Psychoneuroendocrinology 2006, 31:889-894.
32. Whitney A.R., Diehn M., Popper S.J., Alizadeh A.A., Boldrick J.C., Relman D.A., et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U. S. A 2003, 100:1896-1901.